pillbase.ru

Omjjara

Active substance: momelotinib

Momelotinib dihydrochloride monohydrate

Centralised EU authorisationActive

Marketing holder: GlaxoSmithKline Trading Services Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • Ojjaara
    TABLET · MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE 200 mg/1
    81864-101
    GlaxoSmithKline LLC
  • Ojjaara
    TABLET · MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE 150 mg/1
    81864-102
    GlaxoSmithKline LLC
  • Ojjaara
    TABLET · MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE 100 mg/1
    81864-103
    GlaxoSmithKline LLC
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-3661-7e42-a0c4-b2df1a4cdba7,01a1208c-d9dd-79b8-8770-8541a93223cf,01a1209c-5170-7a7b-8b61-aa9ffce49378;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005768
Registration status
Active
Sources
  • product · EMA · EMEA/H/C/005768 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005768 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005768 · Verified 2026-10-09